Home / Ifosfamide / Norway
NO ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Norway
Is there an Ifosfamide shortage in Norway?
Yes. As of 2 Nov 2026, 3 Ifosfamide products are reported short in Norway, the first since 15 Jan 2026. The company estimate for the return is 1 Jan 2027. Main reason: manufacturing problem.
Also short in United States, Germany, France, Italy, Austria, Belgium, Switzerland, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Holoxan 1000 mg pulver til injeksjons-/infusjonsvæske, oppløsning, 1000 mg hetteglass | Baxter Medical Ab | 15 Jan 2026 | 1 Jan 2027 | Manufacturing problem Produksjons- og distribusjonsproblemer |
| NO | Holoxan 2000 mg pulver til injeksjons-/infusjonsvæske, oppløsning, 2000 mg hetteglass | Baxter Medical Ab | 15 Jan 2026 | 1 Jan 2027 | Manufacturing problem Produksjons- og distribusjonsproblemer |
| NO | Holoxan 500 mg pulver til injeksjons-/infusjonsvæske, oppløsning, 500 mg hetteglass | Baxter Medical Ab | 15 Jan 2026 | 1 Jan 2027 | Manufacturing problem Produksjons- og distribusjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).